Stance Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Stance Capital's AMGN Position: Q2 2026 in Review
Stance Capital increased its Amgen (AMGN) stake by 263% in Q2 2026, buying an estimated $3.34M and bringing the position to 13,480 shares worth $4.88M. The position accounts for 1.49% of the portfolio, ranked #6.
Stance Capital first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Stance Capital held 13,480 shares of Amgen worth $4.88M as of Q2 2026.
- Stance Capital bought 9,762 Amgen shares in Q2 2026, an estimated $3.34M.
- Amgen made up 1.49% of Stance Capital's portfolio in Q2 2026, its #6 holding.
- Stance Capital first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
- 3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.